Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include MicroRNA in disease regulation, Cancer-related molecular mechanisms research, RNA Interference and Gene Delivery, and RNA modifications and cancer.
Tetrastigma Hemsleyanum Polysaccharide Suppresses Triple-Negative Breast Cancer by Disrupting the Hippo-YAP/TEAD4-PDIA4 Axis and Endoplasmic Reticulum Stress Adaptation.
LncRNA LINC00667 inhibits breast cancer progression by regulating POTEE to suppress mitochondrial oxidative phosphorylation.
TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mTOR pathway and is a therapeutic target
Synergistic effects of PS-NPs and Cd on ovarian toxicity in adolescent rats: Ferroptosis by induction of mitochondrial redox imbalance via the SIRT3-SOD2/Gpx4 pathway
Differentially expressed tRNA-derived fragments and their roles in primary cardiomyocytes stimulated by high glucose
LncRNA HCP5-Encoded Protein Regulates Ferroptosis to Promote the Progression of Triple-Negative Breast Cancer
Genomic Landscape and Potential Regulation of RNA Editing in Drug Resistance.
ncFO: A Comprehensive Resource of Curated and Predicted ncRNAs Associated with Ferroptosis.
Cadmium exposure induces osteoporosis through cellular senescence, associated with activation of NF-κB pathway and mitochondrial dysfunction
Single-cell RNA-seq dissects the intratumoral heterogeneity of triple-negative breast cancer based on gene regulatory networks.
<scp>CPEB1</scp> enhances erastin‐induced ferroptosis in gastric cancer cells by suppressing twist1 expression
LncRNA HCP5 Encoding Protein Regulates Ferroptosis To Promote The Progression of Triple Negative Breast Cancer
LncRNA-Encoded Peptide: Functions and Predicting Methods.
ncEP: A Manually Curated Database for Experimentally Validated ncRNA-encoded Proteins or Peptides.
ncRI: a manually curated database for experimentally validated non-coding RNAs in inflammation
ncRI: a manually curated database for experimentally validated non-coding RNAs in inflammation.
Identification of drug resistance associated ncRNAs based on comprehensive heterogeneous network.
LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR‐219a‐5p
LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.
Drug Resistance-Related Competing Interactions of lncRNA and mRNA across 19 Cancer Types
Identification of transcription factor-miRNA-lncRNA feed-forward loops in breast cancer subtypes.
High glucose promotes hepatic fibrosis via miR‑32/MTA3‑mediated epithelial‑to‑mesenchymal transition
Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy
LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy
Systematical analysis of lncRNA–mRNA competing endogenous RNA network in breast cancer subtypes
MiR-139-5p regulates VEGFR and downstream signaling pathways to inhibit the development of esophageal cancer
Identification of transcription factor-miRNA-lncRNA feed-forward loops in breast cancer subtypes
A Combination of SAHA and Quinacrine Is Effective in Inducing Cancer Cell Death in Upper Gastrointestinal Cancers
Long non-coding RNA MIAT promotes breast cancer progression and functions as ceRNA to regulate DUSP7 expression by sponging miR-155-5p
ncDR: a comprehensive resource of non-coding RNAs involved in drug resistance